CYNFONERA
Live / Registered — Registered (as of 30 Dec 2025)
What this means for you
Registered since 30 Dec 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Dec 2031: the §8 declaration of use).
Record
- Serial number
- 99036264
- Registration number
- 8083338
- Mark type
- Word mark
- Filed
- 11 Feb 2025
- Published for opposition
- 10 Jun 2025
- Registered
- 30 Dec 2025
- Next maintenance filing
- §8 declaration of use, due by 30 Dec 2031 (grace period to 30 Jun 2032)
- Attorney of record
- BRETT MANCHEL
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of renal diseases, cardiovascular diseases, ophthalmic diseases, liver diseases, pulmonary diseases, metabolic diseases, vascular diseases and fibrosis
Owner
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, Leverkusen, DE
- Bayer Aktiengesellschaft, Leverkusen, DE
Prosecution history
- 30 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 Dec 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 13 Oct 2025 — NOTICE OF ALLOWANCE CANCELLED
- 05 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Oct 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 May 2025 — ASSIGNED TO EXAMINER
- 11 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 11 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Feb 2025 — NEW APPLICATION ENTERED